Close Menu

NEW YORK (GenomeWeb) – Cancer Genetics reported today that its third quarter revenues were up 68 percent year over year.

The oncology-focused clinical services firm reported total Q3 revenues of $6.8 million compared to $4 million in Q3 2015. 

The firm reported a 204 percent increase in clinical services test volume to 7,334 tests, driven by an increase in immuno-oncology testing, companion diagnostic testing for PD-L1, and solid tumor profiling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.